Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Cavendish
Nanjing, Jiangsu, China
- Ownership
- Private
- Employees
- ~300
- Development stage
- Other
01
Overview
Nanjing Cavendish Bio-engineering Technology Co., Ltd. is a high-tech pharmaceutical company based in Nanjing, China, specializing in the research, development, and commercialization of innovative and high-end generic drugs. Founded in 2006, the company has established a strong presence in oncology, cardiovascular, and ophthalmology therapeutic areas. It is notably recognized for being the first to launch generic Pomalidomide and Eplerenone in the Chinese market, often utilizing patent challenges to accelerate market entry. In 2024, the company entered into a significant strategic partnership and equity investment agreement with Grand Pharmaceutical Group to further enhance its R&D capabilities and market reach. Nanjing Cavendish operates under the Marketing Authorization Holder (MAH) model, focusing on R&D while collaborating with various manufacturing partners to bring its products to market.
- Therapeutic areas
- HematologyCardiovascularPulmonologyOncologyOphthalmology
- Modalities
- Small moleculePeptidesNano-suspension
- Industry
- Biotech
02
Partnerships
Grand Pharmaceutical GroupJiangsu Yunyang Group Pharmaceutical Co., Ltd.Jiangsu Wuzhong Pharmaceutical Group
Beyond the preview
Go deeper on Nanjing Cavendish.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nanjing Cavendish.